Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Benelux Stocks: ASML Holding, Devgen, Ion Beam Applications

May 17 (Bloomberg) -- The Amsterdam Exchanges Index declined 0.67, or 0.2 percent, to 326.57, reversing last week’s 4.8 percent jump. Belgium’s Bel20 Index slipped 8.10, or 0.3 percent, to 2,439.07, a third straight drop.

The following are among the most active stocks in the Benelux markets today. Symbols are in parentheses.

ASML Holding NV (ASML NA), Europe’s largest maker of semiconductor equipment, climbed 1.6 percent to 24.23 euros, snapping two days of declines.

Royal Bank of Scotland Group Plc analyst Didier Scemama maintained a “buy” recommendation on the shares, while downgrading the European semiconductor industry to “neutral” from “overweight.” The London-based analyst said he expects ASML to outperform others in the industry, citing “low valuation and its defensive characteristics.”

Separately, Samsung Electronics Co., the world’s biggest buyer of chip- and display-manufacturing equipment, said capital expenditure will jump to 18 trillion won ($15.6 billion) this year from 8 trillion won in 2009.

Devgen NV (DEVG BB) fell 3 percent to 8.71 euros, a third straight drop. The Belgian developer of hybrid rice, sorghum, pearl millet and sunflower seeds reported a first-quarter net loss of 1.17 million euros ($1.45 million).

Ion Beam Applications SA (IBAB BB) gained 1.1 percent to 7.14 euros, reversing a 2.9 percent drop on May 14. Europe’s biggest maker of proton-therapy equipment was rated “overweight” in new coverage at Exane BNP Paribas.

To contact the reporter on this story: Maud van Gaal in Amsterdam at mvangaal@bloomberg.net

To contact the editor responsible for this story: David Merritt at dmerritt1@bloomberg.net.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.